Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck

Medpace (MEDP) is in a potential buy range with its next earnings report scheduled for Apr. 26.

The medical stock is about 3% above a 177.22 buy point from a second-stage consolidation.


Be aware that buying close to when a stock reports can be risky. You don’t know how the stock will report and how the market will react, and you don’t have enough time to build a profit cushion. You can reduce your risk by waiting to see the actual numbers and the market’s reaction. You can also use an options strategy to limit your potential downside. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips.


Looking For The Best Stocks To Buy And Watch? Start Here

Regarding top and bottom line numbers, the company has posted two quarters of increasing earnings growth. Revenue gains have also increased during the same period.

Analysts expect earnings growth of 31% for the quarter, and 14% growth for the full year. Annual growth estimates were recently revised higher.

Medpace stock has a 95 Composite Rating and holds the No. 1 rank among its peers in the Medical-Research Equipment/Services industry group. Bio-Techne (TECH) and Charles River Labs International (CRL) are also among the group’s highest-rated stocks.

Note: Dates for earnings reports are subject to change. Check the company’s website for any updates.


MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks



Most Related Links :
reporterwings Governmental News Finance News

Source link

Back to top button